Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You sure can buy alot of swedish fish.
So if you buy 500 aiki shares at .74 today on may 4th they will give you 1 Hoth share at 3.56?
Green close on the way?
From 1-70 now 1-500, they can shove those 1-500 shares in the CEO's ass and whoever came up with those number.
How they played with that. 1-70 then it was 1-170 then it was back to 1-70 then 1-500.
At least we will be dry.
I thought that albeit the guarded success of Redesivir
in yesterdays news would have today generated a carryover ripple effect across most Covid-19 related stocks. Well, apparently not this one. We should have drifted up a bit. I'm wondering why not? Probably it's that strategically suppressed news and our very talented band of shorters.
I’m laughing in your face. See you at .50c haha
AIKI when you sell,BLOW WAVE coming,my $3.00-5.00 run is set up,loaded here with 24,555 shares
That’s why you sell today and move on. Lots of time wasted
agreed bud ,I want my spike $3-5 pps here and done
Also stares they will discussing when to distribute it.April 30th was last day if you have not purchased Aiki stock. I dont give crap about the dividends I know Aiki going to spike back from 3-5 if there is real meat on the plate maybe more this time around I will sell and not look back depends though :)
Good luck to all
The IDIOTS know my name and know when I buy. They seat on it...waiting for me to get lost. AND I DO THE SAME....day after day....lol
But I am piling all energy on the stock to use these idiots and keep it here. I always want a ready meal to fall back into. And AIKI is it!!! Every morning now, I start buying by 7 am and play around, STRATEGICALLY
Haaa haaa! You crack me up bro. AIKI doesn't follow those rules. The trading is dependent on my posts and stock moves. Sounds strange or ridiculous but 100 percent truth!!!!!
AIKI...73...Inverted hammer should bounce this off the 20ma support line...imo...we shall see...
Yes, I saw that. I thought to myself, "it's just a typo".
'How stupid wound it be for AIKI to orchestrate such an infantile scam on its own original patrons. We here hunger to survive but not on Blood Money.
Additionally, with regards to the previously announced distribution of Hoth Therapeutics, Inc. (“Hoth”) shares to the Company’s stockholders, the Company reports that Hoth has registered the shares to be distributed and the new record date for the distribution is April 30, 2020. Each Company stockholder will be entitled to receive one (1) share of Hoth common stock for every five hundred (500) shares of AIkido common stock.
Just the facts please:
To my knowledge until I see in actual writing, the Dividend is just that, a Dividend. You still get to keep all your AIKI shares. They're not coming to take your guns away. lol
Second, it would be stupid for AIKI to change the dispersement from 70 to 500 shares per one share of HOTH. That would just set themselves up for an embarrassing class action lawsuit. All those who purchased on the basis of that March 13th PR will be thoroughly pissed. I am confident both Managements of AIKI and HOTH don't need or desire that attention.They're smarter than that.
If you come across any contrary info to these conclusions, please supply reference. GLTU
NEW YORK, March 13, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), formerly known as Spherix Incorporated, today announced that the record date and distribution date have changed for the previously announced distribution to AIkido stockholders of 70,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by AIkido.
Each AIkido stockholder will be entitled to receive one (1) share of Hoth common stock for every seventy (70) shares of AIkido common stock held as of 5 p.m. Eastern Time on March 16, 2020, the new record date. The distribution date of the dividend distribution is anticipated to occur on or around April 30, 2020; however, this date is subject to change based upon the filing date of a registration statement by Hoth.
This has changed see security filing now you get for every 500 shares ok Aiki 1 share of Hoth
always late to the party f 'retireat40',AIKI GONNA BLAST like suicide BOMB,load fast now
AIKI~lol not a pinkie F 'retireat40' ,is a NASDAQ monsta ,will be soon and $10.00 PPS with FDA news,load turdo up
check L2 fast,crazy spike anytime,MMs holding here,when will break will run 300-500%% in the air,look into AIKI history
AIKI~here is not a pinkie do land,got my 20,000 shares load here 'retireat40'
load now dude,look at the chart and news and SPIKE TO 3.00-5.00 COMINGGGGG,'retireat40'
Just like NMHL* ran to $15? Oops it's currently at .42
AIKI will run to $3.00-5.00 dollars with the first news,LOAD UP ASAP,the history repeats
Did anyone attend the online HOTH Presentation yesterday?
No PR out yet. What's the latest? TIA
Just curious why you need to post the current day share price, everyday on all stocks that you are a moderator? You know that pretty easy to find.
Why do I get the sneaking suspicion
they will extend the Date of Record? Why not? Its worked before? lol
f MMS will let it go,no chance here,freaking $3-5.00 dollars coming
Hasn’t had any volume for days now you think it’s gonna pop for no reason ? Your crazy
Aside from that teaser 1-70 Hoth dividend,
I'm wondering what an old fashion, stock for stock, merger would actually look like. How many shares of HOTH is actually worth one AIKI? The measly dividend was always just a teaser. Ideally, AIKI should hold onto its cash for the next strategic acquisition. ALTA
AIKI strong bull,my $3-5 dollars pps coming
.76 freaking resistance and after 1.00 in no time
AIKI im here for MONSTA NEWS TO $3.00-5.00 ,not leaving with my 20,000 shares
AIKI my $3-5 dollars pps coming with in a week
Followers
|
156
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8287
|
Created
|
12/30/04
|
Type
|
Free
|
Moderators |
Kucera Paper Lipid Nucleoside Conjugates for the Treatment of Cancer
Kucers & Pardee Paper Improving Nucleoside Analogs via Lipid Conjugation
The Phospholipid Gemcitabine Conjugate, KPC34, is a Novel Treatment for Leukemia
Short-term Toxicity Study of DHA-dFdC
AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices,
but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual
and institutional investor includes stock price and history, upcoming events and presentations and financial documents.
AIkido Pharma Inc. is traded on the Nasdaq under the ticker symbol AIKI.
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.
The Spherix platform contains patented technology from leading universities and researchers and we seek to develop
our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University.
Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Our pancreatic treatment has shown positive preclinical results for inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.
The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms observed with the current standard of care.
In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
https://ir.aikidopharma.com/stock-information/
$AIKI Spherix Incorporated, a biotechnology company,focuses on developing small-molecule anti-cancer therapeutics.
Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
The company's platform consists of patented technology from leading universities and researchers and in the process of developing an
innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at
Austin and Wake Forest University.
It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic
markers in people that indicate an increased risk of developing pancreatic cancer.
Spherix Incorporated was founded in 1967 and is based in New York, New York.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |